Complex I disorders: causes, mechanisms, and development of treatment strategies at the cellular level.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Developmental Disabilities Research Reviews

• Publication date

  2010-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ddrr.107PMID 20818732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mammalian Mitochondrial Complex I: Biogenesis, Regulation, and Reactive Oxygen Species Generation

  2010cited by this paper
• The on-off switches of the mitochondrial uncoupling proteins.

  2010cited by this paper
• Detection and manipulation of mitochondrial reactive oxygen species in mammalian cells.

  2010cited by this paper
• The architecture of respiratory complex I

  2010cited by this paper
• Mitochondria‐targeted antioxidant SkQR1 selectively protects MDR (Pgp 170)‐negative cells against oxidative stress

  2010cited by this paper
• Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice.

  2010cited by this paper
• Biochemical diagnosis of mitochondrial disorders

  2010cited by this paper
• Mitochondrial respiratory chain dysfunction variably increases oxidant stress in Caenorhabditis elegans.

  2010cited by this paper
• Resveratrol Protects Mitochondria against Oxidative Stress through AMP-Activated Protein Kinase-Mediated Glycogen Synthase Kinase-3β Inhibition Downstream of Poly(ADP-ribose)polymerase-LKB1 Pathway

  2009cited by this paper
• Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease.

  2009cited by this paper
• The antioxidant Trolox restores mitochondrial membrane potential and Ca2+-stimulated ATP production in human complex I deficiency

  2009cited by this paper
• Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.

  2009cited by this paper
• Mitochondrial medicine: entering the era of treatment

  2009cited by this paper
• Penetrating cation/fatty acid anion pair as a mitochondria-targeted protonophore

  2009cited by this paper
• Calcium and ATP handling in human NADH:ubiquinone oxidoreductase deficiency.

  2009cited by this paper
• Mitochondria-Targeted Antioxidant MitoQ10 Improves Endothelial Function and Attenuates Cardiac Hypertrophy

  2009cited by this paper
• Grape Extract Protects Mitochondria from Oxidative Damage and Improves Locomotor Dysfunction and Extends Lifespan in a Drosophila Parkinson's Disease Model

  2009cited by this paper
• Resveratrol induces mitochondrial biogenesis in endothelial cells

  2009cited by this paper
• Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases

  2009cited by this paper
• An attempt to prevent senescence: a mitochondrial approach.

  2009cited by this paper
• Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells

  2009cited by this paper
• C6ORF66 is an assembly factor of mitochondrial complex I.

  2008cited by this paper
• Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells

  2008cited by this paper
• Structure of the voltage dependent anion channel: state of the art

  2008cited by this paper
• Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals

  2008cited by this paper
• Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease.

  2008cited by this paper
• Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease.

  2008influential reference
• A mitochondrial protein compendium elucidates complex I disease biology.

  2008cited by this paper
• Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and Age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke)

  2008cited by this paper
• Mitigation of NADH: ubiquinone oxidoreductase deficiency by chronic Trolox treatment.

  2008cited by this paper
• Mitochondrial Ca2+ homeostasis in human NADH:ubiquinone oxidoreductase deficiency.

  2008cited by this paper
• Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: Synthesis and in vitro studies

  2008cited by this paper
• Ultrastructure of the Mitochondrion and Its Bearing on Function and Bioenergetics

  2008cited by this paper
• NDUFA2 complex I mutation leads to Leigh disease.

  2008influential reference
• Mitochondrial complex I deficiency caused by a deleterious NDUFA11 mutation

  2008cited by this paper
• Human CIA30 is involved in the early assembly of mitochondrial complex I and mutations in its gene cause disease

  2007cited by this paper
• Superoxide production is inversely related to complex I activity in inherited complex I deficiency.

  2007cited by this paper
• Alzheimer's disease: a lesson from mitochondrial dysfunction.

  2007cited by this paper
• X‐linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy

  2007cited by this paper
• A dynamic machinery for import of mitochondrial precursor proteins

  2007cited by this paper
• Mitochondrial complex I: Structure, function and pathology

  2006cited by this paper
• Decreased agonist-stimulated mitochondrial ATP production caused by a pathological reduction in endoplasmic reticulum calcium content in human complex I deficiency.

  2006influential reference
• Ca2+-mobilizing agonists increase mitochondrial ATP production to accelerate cytosolic Ca2+ removal: aberrations in human complex I deficiency.

  2006influential reference
• Inhibition of complex I of the electron transport chain causes O2-. -mediated mitochondrial outgrowth.

  2005cited by this paper
• Biochemical and molecular diagnosis of mitochondrial respiratory chain disorders.

  2004cited by this paper
• Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome

  2004influential reference
• Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases

  2004cited by this paper
• Inhibition of Mitochondrial Na (cid:1) -Ca 2 (cid:1) Exchange Restores Agonist-induced ATP Production and Ca 2 (cid:1) Handling in Human Complex I Deficiency*

  2004cited by this paper
• Mitochondria in health and disease: perspectives on a new mitochondrial biology.

  2004cited by this paper
• Inhibition of Mitochondrial Na+-Ca2+ Exchange Restores Agonist-induced ATP Production and Ca2+ Handling in Human Complex I Deficiency*

  2004cited by this paper
• Inhibitors of the Quinone-binding Site Allow Rapid Superoxide Production from Mitochondrial NADH:Ubiquinone Oxidoreductase (Complex I)*

  2004cited by this paper
• NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency.

  2004cited by this paper
• Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency.

  2004influential reference
• Some practical aspects of providing a diagnostic service for respiratory chain defects

  2003cited by this paper
• Nutritional cofactor treatment in mitochondrial disorders.

  2003cited by this paper
• Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy

  2003influential reference
• Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy

  2001influential reference
• Th1 or Th2: How an appropriate T helper response can be made

  2001cited by this paper
• Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells

  2001cited by this paper
• Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency.

  2001influential reference
• Human NADH:Ubiquinone Oxidoreductase

  2001cited by this paper
• The genetics and pathology of oxidative phosphorylation

  2001cited by this paper
• Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I

  1999influential reference
• Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy

  1999influential reference
• Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit.

  1998cited by this paper
• The first nuclear-encoded complex I mutation in a patient with Leigh syndrome.

  1998influential reference
• Sarco(endo)plasmic reticulum Ca2+ pump isoform SERCA3 is more resistant than SERCA2b to peroxide.

  1997cited by this paper
• Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease.

  1988cited by this paper
• Inhibition of mitochondrial ATPase by Hg++ ions.

  1978cited by this paper

• Epigenetic Mechanisms, Assessment and Therapeutics of Epidermal Stem Cells in Skin Aging

  2025cites this paper
• The flexible chain: regulation of structure and activity of ETC complexes defines rate of ATP synthesis and sites of superoxide generation

  2025cites this paper
• Berberine dissociates mitochondrial complex I by SIRT3-dependent deacetylation of NDUFS1 to improve hepatocellular glucose and lipid metabolism

  2025cites this paper
• CRISPR-Cas9 mediated knockout of NDUFS4 in human iPSCs: A model for mitochondrial complex I deficiency.

  2024cites this paper
• To boldly go where no microRNAs have gone before: spaceflight impact on risk for small-for-gestational-age infants

  2024cites this paper
• A ketogenic diet alters mTOR activity, systemic metabolism and potentially prevents collagen degradation associated with chronic alcohol consumption in mice

  2023cites this paper
• Aberrant and glutamate metabolism linked to regional neurodegeneration in a mouse model of Leigh syndrome.

  2021cites this paper
• Respiratory Complex I dysfunction in cancer: from a maze of cellular adaptive responses to potential therapeutic strategies

  2021cites this paper
• Mitochondrial mutations and mitoepigenetics: focus on regulation of oxidative stress-induced responses in breast cancers.

  2020cites this paper
• Metallothionein 1 Overexpression Does Not Protect Against Mitochondrial Disease Pathology in Ndufs4 Knockout Mice

  2020cites this paper
• NDUFS4 deletion triggers loss of NDUFA12 in Ndufs4-/- mice and Leigh syndrome patients: A stabilizing role for NDUFAF2.

  2020cites this paper
• Metallothionein 1 Overexpression Does Not Protect Against Mitochondrial Disease Pathology in Ndufs4 Knockout Mice

  2020cites this paper
• Plant Polyphenols as Neuroprotective Agents in Parkinson's Disease Targeting Oxidative Stress.

  2020cites this paper
• Metabolic Myopathies II

  2020cites this paper
• Identification and Characterization of New Variants in FOXRED1 Gene Expands the Clinical Spectrum Associated with Mitochondrial Complex I Deficiency

  2019cites this paper
• Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies

  2019cites this paper
• Convergent patterns of evolution of mitochondrial oxidative phosphorylation (OXPHOS) genes in electric fishes

  2019cites this paper
• Metabolomics of Ndufs4-/- skeletal muscle: Adaptive mechanisms converge at the ubiquinone-cycle.

  2019cites this paper
• Mechanisms of Disease Monogenic Mitochondrial Disorders

  2018cites this paper
• in children : toward development of small-molecule treatment strategies

  2018cites this paper
• Novel causes, mechanisms and therapeutic strategies in mitochondrial disease

  2018cites this paper
• Antidepressants are cytotoxic to rat primary blood brain barrier endothelial cells at high therapeutic concentrations.

  2017cites this paper
• Characterization of the Ndufs4-/-model to evaluate a novel therapeutic strategy towards mitochondrial dysfunction

  2017cites this paper
• Adverse effects of anti-tuberculosis drugs on HepG2 cell bioenergetics

  2017cites this paper
• Resveratrol attenuates oxidative stress in mitochondrial Complex I deficiency: Involvement of SIRT3.

  2016cites this paper
• Mitochondrial disorders in children: toward development of small‐molecule treatment strategies

  2016cites this paper
• -Adrenoceptor/cAMP/Protein Kinase A Axis during Oxidative Stress

  2015cites this paper
• Mitochondrial dysfunction in primary human fibroblasts triggers an adaptive cell survival program that requires AMPK-α.

  2015cites this paper
• Complete Mitochondrial Complex I Deficiency Induces an Up-Regulation of Respiratory Fluxes That Is Abolished by Traces of Functional Complex I1[OPEN]

  2015cites this paper
• Evolution of FOXRED1, an FAD-dependent oxidoreductase necessary for NADH:ubiquinone oxidoreductase (Complex I) assembly.

  2015cites this paper
• Skeletal muscle mitochondria of NDUFS4-/- mice display normal maximal pyruvate oxidation and ATP production.

  2015cites this paper
• of respiratory

  2015cites this paper
• Glutathione metabolism links FOXRED1 to NADH:ubiquinone oxidoreductase (complex I) deficiency: A hypothesis.

  2015cites this paper
• Strategies for Preventing Age and Neurodegenerative Disease-associated Mitochondrial Dysfunction

  2015cites this paper
• How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models.

  2015cites this paper
• PARP Inhibition Delays Progression of Mitochondrial Encephalopathy in Mice

  2014cites this paper
• Regulation and quantification of cellular mitochondrial morphology and content.

  2014cites this paper
• Investigating the mechanism of clonal expansion of deleted mtDNA species

  2014cites this paper
• Investigating the function of [2Fe–2S] cluster N1a, the off-pathway cluster in complex I, by manipulating its reduction potential

  2013cites this paper
• cAMP and mitochondria.

  2013cites this paper
• Mitochondrial complex I.

  2013cites this paper
• Primary fibroblasts of NDUFS4(-/-) mice display increased ROS levels and aberrant mitochondrial morphology.

  2013cites this paper
• Mitochondrial Disorders Caused by Nuclear Genes

  2013influential citation
• The Clinical Spectrum of Nuclear DNA-Related Mitochondrial Disorders

  2013cites this paper
• Complex Subunits and Assembly Genes: Complex I

  2013cites this paper
• Monogenic mitochondrial disorders.

  2012cites this paper
• conplastic strains phosphorylation and insulin sensitivity in rat are linked to effects on oxidative

  2012cites this paper
• BIOCHEMICAL AND GENETIC APPROACHES TO UNRAVEL MITOCHONDRIAL COMPLEX I DEFICIENCY

  2012cites this paper
• Selective screening of metabolic diseases in Estonia: the application of new diagnostic methods

  2012cites this paper
• New pathophysiological concepts and potential therapeutic targets for oxidative phosphorylation disorders

  2012cites this paper
• Metabolic consequences of NDUFS4 gene deletion in immortalized mouse embryonic fibroblasts.

  2012cites this paper
• Metabolic autopsy with postmortem cultured fibroblasts in sudden unexpected death in infancy: diagnosis of mitochondrial respiratory chain disorders.

  2012cites this paper
• Nonsynonymous variants in mt-Nd2, mt-Nd4, and mt-Nd5 are linked to effects on oxidative phosphorylation and insulin sensitivity in rat conplastic strains.

  2012cites this paper
• Pharmacological targeting of mitochondrial complex I deficiency: the cellular level and beyond.

  2012cites this paper
• Mitochondrial complex III stabilizes complex I in the absence of NDUFS4 to provide partial activity.

  2012cites this paper
• Mouse Studies to Shape Clinical Trials for Mitochondrial Diseases: High Fat Diet in Harlequin Mice

  2011cites this paper
• Isolated mitochondrial complex I deficiency: explorative data analysis of patient cell parameters.

  2011cites this paper
• Natural Antibodies against Several Pneumococcal Virulence Proteins in Children during the Pre-Pneumococcal-Vaccine Era: the Generation R Study

  2011cites this paper
• Metabolic disorders of fetal life: glycogenoses and mitochondrial defects of the mitochondrial respiratory chain.

  2011cites this paper
• Heterozygous mutation in the X chromosomal NDUFA1 gene in a girl with complex I deficiency.

  2011cites this paper
• Review: The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis

  2011cites this paper
• The use of individual patient's fibroblasts in the search for personalized treatment of nuclear encoded OXPHOS diseases.

  2011cites this paper
• Mammalian Mitochondrial Complex I: Biogenesis, Regulation, and Reactive Oxygen Species Generation

  2010cites this paper